LC
LABD icon

Lindbrook Capital’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Lindbrook Capital’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20
Closed -$14K – 1800
2020
Q2 		$14K Buy
+20
New +$25.1K ﹤0.01% 727

Other funds holding LABD

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Lindbrook Capital's LABD Position: Q3 2020 in Review

Lindbrook Capital sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2020, closing a stake of 20 shares — an estimated $14K sold.

Lindbrook Capital first reported a position in LABD in Q2 2020 and held it in 1 quarter. The position peaked at $14K in Q2 2020. 12 funds tracked by Wall St. Rank hold LABD as of Q3 2020.

  • Lindbrook Capital reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2020 after selling out during the quarter.
  • Lindbrook Capital sold 20 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2020, an estimated $14K.
  • Lindbrook Capital first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2020 and held it in 1 quarter.
  • Lindbrook Capital's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $14K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2020.

Based on Lindbrook Capital's 13F filing for Q3 2020, filed 3 Nov 2020.